Company intelligence / Profile preview

Time Boost Capital

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Time Boost Capital is a £20-30 million genomics-focused venture fund investing in emerging life sciences startups graduating from Illumina Accelerator programs. The fund supports companies developing novel therapeutics, diagnostics, research tools, and synthetic biology applications to impact human health. It has provided match funding to several startups, notably Alchemab Therapeutics and Broken String Biosciences, empowering their commercial and technical growth through post-accelerator fundraising rounds.[1][3][5]

Modalities: Small moleculeMonoclonal antibodyDiagnosticsSynthetic biologyResearch tools
Industry: Investors

Partnerships

IlluminaIllumina AcceleratorIllumina VenturesLifeArc

Beyond the preview

Go deeper on Time Boost Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Time Boost Capital.

Explore the full profile